Cargando…
In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
OBJECTIVE(S): A variety of signaling molecules have been identified that play a role in angiogenesis, of prime importance, vascular endothelial growth factor (VEGF) and its resceptor (VEGFR), which is highly expressed in most human solid tumors. Targeting VEGF or/and VEGFR with immunotoxin may be a...
Autores principales: | Hosseininejad-Chafi, Mohammad, Alirahimi, Ehsan, Ramezani, Behzad, Oghalaie, Akbar, Sotoudeh, Nazli, Ghaderi, Hajarsadat, Kazemi-Lomedasht, Fatemeh, Habibi-Anbouhi, Mahdi, Moazzami, Reza, Behdani, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118281/ https://www.ncbi.nlm.nih.gov/pubmed/35656448 http://dx.doi.org/10.22038/IJBMS.2021.54293.12195 |
Ejemplares similares
-
Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021) -
Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023) -
Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
por: Ranjibar, Farideh, et al.
Publicado: (2018) -
Development of polyclonal heavy chain antibodies targeting programmed death ligand-1
por: Oghalaie, Akbar, et al.
Publicado: (2023) -
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021)